Darin J. Weber, PhD

Dr. Weber has served as our Chief Regulatory Officer since December 2022, having served as Senior Vice President of Regulatory Development since September 2020, where Dr. Weber is responsible for leading the development and implementation of ProKidney’s regulatory strategy in all markets, worldwide, and interfacing with regulatory authorities. Dr. Weber has over 30 years of experience in cellular and tissue-based regenerative medicine products, with previous roles as Senior Vice President of Regulatory and Quality at Medeor Therapeutics from February 2016 to December 2019; Executive Vice President of Global Regulatory Affairs and Quality Management at Mesoblast from June 2011 to February 2016; Senior Consultant for Cell and Gene Therapies at Biologics Consulting Group from February 2004 to May 2011, and positions of increasing responsibility at the FDA’s CBER, including as Chief of Cellular Therapies Branch in the Office of Cellular, Tissue and Gene Therapies (now known as the Office of Therapeutic Products) from September 1996 to January 2004. He recently concluded 20 years of service as a volunteer member on several United States Pharmacopeia (USP) expert committees for human tissues and advanced therapies. Dr. Weber received his B.S. in Molecular Biology from The Evergreen State College and a Ph.D. in Biochemistry and Biophysics from Oregon State University.